Deep science startup Iom Bioworks has captured the attention of both investors and healthcare professionals. The company recently raised Rs 4 crore in a seed funding round led by Inflection Point Ventures (IPV), a Gurugram-based angel investment firm. With this new capital, Iom Bioworks plans to expand its marketing efforts, secure intellectual property claims, strengthen its core infrastructure, and scale both its scientific and commercial teams.
This funding round marks a significant milestone for Iom Bioworks, as it continues its mission to revolutionize personalized health through targeted modulation of the gut microbiome.
The Founders Behind the Vision
In 2022, Bipin Pradeep Kumar, Dr. Samik Ghosh, and Dr. Hiroaki Kitano founded Iom Bioworks. These founders brought together deep expertise in biotechnology, artificial intelligence, and healthcare. They recognized the critical role that gut bacteria play in human health and saw an opportunity to leverage AI to create personalized health solutions.
The team built Iom Bioworks with a clear goal: to personalize health by identifying key bacteria in the gut and modulating them in a targeted way. They designed a patented platform that combines large-scale knowledge graphs, artificial intelligence, and advanced modeling techniques. This platform enables the company to deliver precise and personalized recommendations to users, helping them improve their gut health and overall well-being.
The Science Behind Gut Health
Modern lifestyles often contribute to poor gut health. People consume unhealthy diets, experience high levels of stress, and suffer from sleep deprivation. These factors disrupt the gut microbiome, leading to various health issues.
The gut microbiome contains trillions of microorganisms, including bacteria, viruses, and fungi. These microorganisms play crucial roles in digestion, immunity, metabolism, and even mental health. When the microbiome stays balanced, it supports overall well-being. But when harmful bacteria outnumber beneficial ones, people experience digestive issues, weakened immunity, mood disorders, and metabolic diseases.
Iom Bioworks addresses these issues by analyzing each person’s gut microbiome and identifying the specific bacteria that influence their health. The company uses its AI-powered platform to process large volumes of data, map complex relationships between microorganisms, and deliver personalized recommendations. These recommendations include dietary suggestions, prebiotic formulations, and lifestyle changes designed to restore and maintain gut health.
Impressive Growth in the First Year
In its first year of operations, Iom Bioworks served over 500 customers. The startup successfully delivered personalized microbiome services across India, thanks to its Pan India logistics network and digital platforms that make its services easily accessible.
The company also made significant progress in protecting its intellectual property. It secured two patents and has another two patents in advanced stages of approval. These patents strengthen Iom Bioworks’ competitive advantage and establish its position as a leader in the deep science healthtech space.
The company further demonstrated its scientific credibility by publishing key research articles in leading scientific journals. These publications validate the effectiveness of its platform and position Iom Bioworks at the forefront of gut microbiome research.
Strategic Support from Inflection Point Ventures
Inflection Point Ventures recognized the potential of Iom Bioworks early. IPV’s founder, Vinay Bansal, explained why they chose to invest in the startup. He emphasized the growing prevalence of lifestyle diseases, which stem from factors such as poor diet, chronic stress, and inadequate sleep. Vinay Bansal highlighted the strong link between these diseases and gut health.
He pointed out that the gut microbiome influences not only digestion but also immunity, metabolism, and even mood regulation. By helping people understand their microbiome and take proactive steps to balance it, Iom Bioworks offers a promising approach to preventing many of these lifestyle diseases and improving overall quality of life.
Vinay Bansal stated, “Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, immunity, metabolism, and even mood. Understanding it can help prevent a myriad of these diseases and also provide a better quality of life.”
The Company’s Vision for the Future
Bipin Pradeep Kumar, one of the co-founders, shared Iom Bioworks’ long-term vision. He envisions a world where people achieve both a healthy mind and body through informed decisions that nurture the microbiome. The company focuses on empowering people to support their inner ecosystem through prebiotics, food choices, and lifestyle adjustments centered on maintaining a balanced microbiome.
Bipin Pradeep Kumar emphasized the importance of their partnership with IPV. He noted that IPV’s support and strategic guidance have strengthened the company’s path forward. Bipin said, “Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome. By empowering our inner ecosystem through prebiotics and a food and lifestyle centred around the bacteria, we aim to energize daily life while preserving the joy of living. Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision.”
The Growing Demand for Personalized Health
Consumers today seek personalized health solutions. They understand that one-size-fits-all approaches often fail to address individual health concerns. Companies like Iom Bioworks respond to this demand by offering customized solutions based on each person’s unique microbiome composition.
As scientific research continues to reveal the powerful influence of the gut microbiome on physical and mental health, demand for such personalized services will likely increase. People want actionable insights into their gut health that lead to tangible improvements in energy levels, digestion, mood, immunity, and long-term disease prevention.
Challenges Ahead
While Iom Bioworks has achieved significant success early on, the company faces several challenges as it scales:
- Consumer Education: Many people remain unaware of the gut microbiome’s importance. The company must continue educating the public to drive wider adoption of its services.
- Competition: As more startups and established healthcare players enter the personalized health space, Iom Bioworks must differentiate itself through scientific rigor, customer experience, and innovative offerings.
- Scientific Advancements: The science behind the gut microbiome continues to evolve. The company must invest in ongoing research to stay ahead of new discoveries.
- Regulatory Compliance: As the healthtech sector grows, government regulations may tighten. The company must proactively comply with evolving health and data privacy regulations.
A Strong Position for Sustainable Growth
Despite these challenges, Iom Bioworks has built a solid foundation. The company combines deep scientific expertise, advanced AI technology, a growing customer base, protected intellectual property, and strong investor backing. This combination positions Iom Bioworks for long-term success in the emerging personalized health sector.
By staying true to its mission of empowering people to take control of their gut health, the company aims to help millions of individuals live healthier, more vibrant lives.
Conclusion
Iom Bioworks has quickly emerged as a pioneering deep science startup addressing one of the most important yet overlooked aspects of modern health: the gut microbiome. The company’s AI-powered platform, scientific leadership, and customer-first approach set it apart in a rapidly growing market. With new funding from Inflection Point Ventures, Iom Bioworks now has the resources to scale its operations, secure its intellectual property, and advance its mission of transforming health through personalized gut microbiome solutions.
As lifestyle diseases continue to rise, companies like Iom Bioworks offer a glimpse into the future of healthcare — one where personalization, prevention, and scientific precision drive better outcomes for individuals worldwide.
Also Read – GIVA Success Story: From Startup to Jewellery Powerhouse